open access

Vol 80, No 1 (2012)
ORIGINAL PAPERS
Published online: 2011-12-21
Submitted: 2013-02-22
Get Citation

The use of selected commercial molecular assays for the microbiological diagnosis of tuberculosis

Aleksandra Safianowska, Renata Walkiewicz, Patrycja Nejman-Gryz, Hanna Grubek-Jaworska
Pneumonol Alergol Pol 2012;80(1):6-12.

open access

Vol 80, No 1 (2012)
ORIGINAL PAPERS
Published online: 2011-12-21
Submitted: 2013-02-22

Abstract


Introduction: We performed a retrospective assessment of the AMPLICOR Mycobacterium tuberculosis (MTB) assay for the molecular diagnosis of tuberculosis based on our own determinations between 1999 and 2009 and a preliminary assessment of the Xpert MTB/RIF system, which we are currently using.
Materials and methods: The study groups comprised 1875 samples (including 104 inhibited samples) and 213 samples, respectively.
Results: The sensitivities of the AMPLICOR MTB and the Xpert MTB/RIF assays were 81.9% and 81.8%, respectively, and their specificities were 97.2% and 99.5%, respectively, versus culture on Loewenstein-Jensen medium. Both assays showed a considerable difference in sensitivity depending on whether the test samples were smear-positive (AFB+) or smearnegative (AFB–). The sensitivities of the AMPLICOR MTB and the Xpert MTB/RIF assays were 97.8% and 100.0%, respectively, for AFB+ samples and 58.1% and 50.0%, respectively, for AFB– samples. Conclusions: Our results confirm full usefulness of the Xpert MTB/RIF assay for routine diagnosis in the case of smearpositive clinical samples.

Abstract


Introduction: We performed a retrospective assessment of the AMPLICOR Mycobacterium tuberculosis (MTB) assay for the molecular diagnosis of tuberculosis based on our own determinations between 1999 and 2009 and a preliminary assessment of the Xpert MTB/RIF system, which we are currently using.
Materials and methods: The study groups comprised 1875 samples (including 104 inhibited samples) and 213 samples, respectively.
Results: The sensitivities of the AMPLICOR MTB and the Xpert MTB/RIF assays were 81.9% and 81.8%, respectively, and their specificities were 97.2% and 99.5%, respectively, versus culture on Loewenstein-Jensen medium. Both assays showed a considerable difference in sensitivity depending on whether the test samples were smear-positive (AFB+) or smearnegative (AFB–). The sensitivities of the AMPLICOR MTB and the Xpert MTB/RIF assays were 97.8% and 100.0%, respectively, for AFB+ samples and 58.1% and 50.0%, respectively, for AFB– samples. Conclusions: Our results confirm full usefulness of the Xpert MTB/RIF assay for routine diagnosis in the case of smearpositive clinical samples.
Get Citation

Keywords

amplifikacja kwasów nukleinowych; gruźlica; reakcja łańcuchowa polimerazy w czasie rzeczywistym

About this article
Title

The use of selected commercial molecular assays for the microbiological diagnosis of tuberculosis

Journal

Advances in Respiratory Medicine

Issue

Vol 80, No 1 (2012)

Pages

6-12

Published online

2011-12-21

Bibliographic record

Pneumonol Alergol Pol 2012;80(1):6-12.

Keywords

amplifikacja kwasów nukleinowych
gruźlica
reakcja łańcuchowa polimerazy w czasie rzeczywistym

Authors

Aleksandra Safianowska
Renata Walkiewicz
Patrycja Nejman-Gryz
Hanna Grubek-Jaworska

Important: This website uses cookies.tanya dokter More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Czasopismo Pneumonologia i Alergologia Polska dostęne jest również w Ikamed - księgarnia medyczna

Wydawcą serwisu jest "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl